HomeIngredientInfluence of products portfolio and process contextualization on the economic performance of small- and large-scale avocado biorefineries

Influence of products portfolio and process contextualization on the economic performance of small- and large-scale avocado biorefineries

October 19, 2022

Bioresour Technol. 2021 Dec;342:126060. doi: 10.1016/j.biortech.2021.126060. Epub 2021 Sep 28.

ABSTRACT

This research paper seeks to evaluate the influence of the context, processing scale, and portfolio of products on the economic performance of different avocado-based biorefineries. For this, two scenarios in small and large-scale biorefineries were compared. The case of scenario 1 (avocado oil, animal feed, and electricity production) was the best small-scale alternative to be implemented in rural zones than scenario 2 (guacamole and electricity production). The minimum Processing Scale for Economic Feasibility was 0.85 and 1.1 ton/day for scenarios 1 and 2. Compared to lactic acid and xylitol production, the large-scale process addressed to produce levulinic acid, furfural, and lignin (scenario 1) was the best option (scenario 2). In scenario 1, the minimum Processing Scale for Economic Feasibility was 15.50 ton/day compared with scenario 2 of 41.95 ton/day. Based on these values, scenario 1 has the highest feasibility of being implemented in countries such as Colombia.

PMID:34597804 | DOI:10.1016/j.biortech.2021.126060

Tags:, , , , , ,

Related Posts

About The Author

Patrick Blanchard MD

Meet Dr. Blanchard Dr. Blanchard’s medical practice is an embodiment of Integrative health which brings conventional and complementary approaches together in a coordinated way. Conveniently located in sunny Florida and over the internet with ValiseMD’s secure HIPPA compliant telXmed servers. Since 1994, patients with a wide range of challenging medical problems have achieved optimum health using the best of natural medicine, judiciously combined with high-tech innovations. Breakthroughs are often achieved even after patients have consulted mainstream specialists and holistic practitioners. Dr. Blanchard is founder and CEO of ValiseMD, Inc. He is board certified in Family Medicine since 1994 and awarded Fellow of the American Academy of Family Physicians in 2001. He received the ‘Teacher of the Year’ award from the University of Kansas School of Medicine at completion of his residency in Family Medicine. He completed a fellowship at Wake Forest University in the field of vascular neurosonology. He holds a medical patent in the field of Gastroenterology. He holds an unrestricted license to practice medicine and surgery in Florida. He started his medical career as a Emergency Medical Technician, then as a Paramedic and later a Medical Doctor.